Cerevel Therapeutics Inc... (CERE)
NASDAQ: CERE
· Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM
Cerevel Therapeutics Fail-to-Deliver
Total FTD Shares
4.78M
Above Average
FTD / Avg. Volume
232.56%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Aug 1, 2024,
Cerevel Therapeutics Inc. has
4,782,602
shares failed to deliver, representing 232.56%
of the average daily volume of
2,056,487
shares. Over the past year, the monthly average FTD is
41,564
shares, with the current level 11407% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Aug 01, 2024 | 44.96 | 4.78M | +8750.44% |
| Jul 16, 2024 | 42.45 | 54.04K | -54.33% |
| Jun 28, 2024 | 40.89 | 118.33K | +80947.95% |
| May 31, 2024 | 40.74 | 146 | +1023.08% |
| Apr 09, 2024 | 42.13 | 13 | -95.02% |
| Mar 28, 2024 | 42.27 | 261 | -91.15% |
| Feb 27, 2024 | 41.31 | 2.95K | +58900.00% |
| Jan 31, 2024 | 41.9 | 5 | -98.33% |
| Dec 22, 2023 | 41.9 | 300 | -52.23% |
| Nov 29, 2023 | 25.35 | 628 | -9.64% |
| Oct 30, 2023 | 23.24 | 695 | -94.49% |
| Sep 29, 2023 | 21.83 | 12.6K | +308.03% |
| Aug 14, 2023 | 22 | 3.09K | +308800.00% |
| Jul 21, 2023 | 29.49 | 1 | -99.83% |
| Jun 29, 2023 | 31.8 | 600 | +1718.18% |
| May 31, 2023 | 32.6 | 33 | -99.36% |
| Apr 28, 2023 | 29.04 | 5.18K | +38.40% |
| Mar 31, 2023 | 24.39 | 3.74K | +356.90% |
| Feb 28, 2023 | 26.69 | 819 | +73.15% |
| Jan 31, 2023 | 34.15 | 473 | n/a |